Evidence map›Paper›PMID 17130626›Full record

ReviewTobacco control2006

Challenging the epidemiologic evidence on passive smoking: tactics of tobacco industry expert witnesses.

John A Francis, Amy K Shea, Jonathan M Samet

Open access · greenAbstract readReview
In one paragraph

Review in Tobacco control, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 29 citations in OpenAlex.

  1. Toolkit for detecting misused epidemiological methods.Environmental health : a global access science source · 2021
    Article
  2. The importance of psychology for shaping legal cannabis regulation.Experimental and clinical psychopharmacology · 2021
    Review
  3. Article
  4. Article
  5. Article
  6. Prevention - Passive smoking and pregnancy.EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.] · 2013
    Review
  7. Article
  8. Quantification of ETS exposure in hospitality workers who have never smoked.Environmental health : a global access science source · 2010
    Review
  9. Article
  10. Tobacco Control and Children: An International Perspective.Pediatric allergy, immunology, and pulmonology · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

John A FrancisInstitute for Global Tobacco Control, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Baltimore, MD 21205, USA.
Amy K Shea
Jonathan M Samet
Johns Hopkins University · US

Funding

ANALYSIS OF TOBACCO DEPOSITIONS AND TRIAL TESTIMONYR01CA087486 · NCI · MICHIGAN PUBLIC HEALTH INSTITUTE · PI DAVIS, RONALD M · 2000 to 2003
$2.8M
NCI NIH HHS CA087486NCI NIH HHS R01 CA087486
6 · The paper itself

Abstract

objectiveTo analyse the statements given by tobacco industry defence witnesses during trial testimonies and depositions in second-hand smoke cases and in parallel, to review criticisms of epidemiology in industry-funded publications in order to identify strategies for discrediting epidemiologic evidence on passive smoking health effects.

methodsA collection of depositions and trial testimony transcripts from tobacco industry-related lawsuits filed in the United States during the 1990s, was compiled and indexed by the Tobacco Deposition and Trial Testimony Archive (DATTA). Statements in DATTA made by expert witnesses representing the tobacco industry relating to the health effects of passive smoking were identified and reviewed. Industry-supported publications within the peer-reviewed literature were also examined for statements on exposure misclassification, meta-analysis, and confounding.

resultsThe witnesses challenged causation of adverse health effects of passive smoking by citing limitations of epidemiologic research, raising methodological and statistical issues, and disputing biological plausibility. Though not often cited directly by the witnesses, the defence tactics mirrored the strategies used in industry-funded reports in the peer-reviewed literature.

conclusionThe tobacco industry attempted to redirect the focus and dialogue related to the epidemiologic evidence on passive smoking. This approach, used by industry experts in trial testimony and depositions, placed bias as a certain alternative to causation of diseases related to passive smoking and proposed an unachievable standard for establishing the mechanism of disease.

Indexed as

Expert TestimonyAnimalsCausalityConfounding Factors, EpidemiologicDisease Models, AnimalEvidence-Based MedicineHumansMeta-Analysis as TopicTobacco IndustryTobacco Smoke PollutionTobacco Smoke Pollution

Identifiers

PMID17130626
PMCPMC2563583
OpenAlexW2123740780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.